175.97 USD
+5.7 (+3.35%)
176.996 USD
+1.03 (+0.58%)
ChartMill assigns a Buy % Consensus number of 86% to INSM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 219.29. This target is 24.62% above the current price.
INSM was analyzed by 25 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about INSM.
In the previous month the buy percentage consensus was at a similar level.
INSM was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-06 | UBS | Maintains | Buy -> Buy |
| 2025-12-18 | TD Cowen | Maintains | Buy -> Buy |
| 2025-12-18 | Guggenheim | Maintains | Buy -> Buy |
| 2025-12-18 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-18 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-12-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-16 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-12-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-15 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-12-11 | TD Cowen | Maintains | Buy -> Buy |
| 2025-12-01 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-20 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-31 | UBS | Maintains | Buy -> Buy |
| 2025-10-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-31 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-31 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-27 | B of A Securities | Maintains | Buy -> Buy |
| 2025-10-14 | UBS | Maintains | Buy -> Buy |
| 2025-10-03 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-02 | TD Cowen | Maintains | Buy -> Buy |
| 2025-09-08 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-03 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-21 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-20 | William Blair | Initiate | Outperform |
| 2025-08-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-14 | Stifel | Maintains | Buy -> Buy |
| 2025-08-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-08-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-08-13 | UBS | Maintains | Buy -> Buy |
| 2025-08-13 | RBC Capital | Maintains | Outperform -> Outperform |
INSMED INC / INSM FAQ
Can you provide the average price target for INSMED INC stock?
25 analysts have analysed INSM and the average price target is 219.29 USD. This implies a price increase of 24.62% is expected in the next year compared to the current price of 175.97.
How do analysts rate INSMED INC (INSM)?
The consensus rating for INSMED INC (INSM) is 85.6 / 100 . This indicates that analysts generally have a positive outlook on the stock.